| 15 | EndocannabinoidsIBA
01/2019
-
09/2008 |
| 8 | Glucose (Dextrose)FDA LinkGeneric
10/2019
-
09/2008 |
| 8 | CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2019
-
09/2008 |
| 5 | LipidsIBA
11/2017
-
09/2008 |
| 4 | JD5037IBA
08/2021
-
08/2012 |
| 4 | CannabinoidsIBA
12/2014
-
06/2004 |
| 3 | RimonabantIBA
08/2021
-
02/2014 |
| 3 | Fatty Acids (Saturated Fatty Acids)IBA
01/2019
-
06/2010 |
| 3 | Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2017
-
11/2006 |
| 3 | EnzymesIBA
01/2017
-
12/2006 |
| 3 | LeptinIBA
02/2014
-
09/2008 |
| 3 | Insulin (Novolin)FDA Link
11/2013
-
09/2008 |
| 2 | Triglycerides (Triacylglycerol)IBA
01/2017
-
02/2014 |
| 2 | CholesterolIBA
01/2017
-
02/2014 |
| 2 | CytochromesIBA
01/2017
-
01/2017 |
| 2 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
05/2015
-
06/2010 |
| 1 | MRI-1867IBA
08/2021 |
| 1 | ArrestinsIBA
10/2019 |
| 1 | Sirtuin 1IBA
01/2019 |
| 1 | Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 |
| 1 | Mechanistic Target of Rapamycin Complex 2IBA
01/2019 |
| 1 | CC ChemokinesIBA
01/2019 |
| 1 | Adrenergic Agents (Adrenergic Drugs)IBA
08/2017 |
| 1 | beta-Arrestin 1IBA
08/2017 |
| 1 | Proteins (Proteins, Gene)FDA Link
01/2017 |
| 1 | olaparibIBA
01/2017 |
| 1 | Methionine (L-Methionine)FDA Link
01/2017 |
| 1 | Choline (Choline Chloride)IBA
01/2017 |
| 1 | Cytochrome P-450 CYP2E1 (CYP2E1)IBA
01/2017 |
| 1 | Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2016 |
| 1 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
10/2015 |
| 1 | anandamide (arachidonylethanolamide)IBA
05/2015 |
| 1 | Diethylnitrosamine (N-Nitrosodiethylamine)IBA
05/2015 |
| 1 | Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
05/2015 |
| 1 | LigandsIBA
05/2015 |
| 1 | Tryptophan (L-Tryptophan)FDA Link
05/2015 |
| 1 | Losartan (Cozaar)FDA LinkGeneric
12/2014 |
| 1 | Angiotensin IIIBA
12/2014 |
| 1 | Hormones (Hormone)IBA
02/2014 |
| 1 | Nonesterified Fatty Acids (NEFA)IBA
02/2014 |
| 1 | AdiponectinIBA
02/2014 |
| 1 | thermozymocidin (myriocin)IBA
01/2014 |
| 1 | CeramidesIBA
01/2014 |
| 1 | cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA
11/2013 |
| 1 | stearoyl-coenzyme A (stearoyl-CoA)IBA
11/2013 |
| 1 | InflammasomesIBA
09/2013 |
| 1 | AM 3506IBA
11/2010 |
| 1 | fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
11/2010 |
| 1 | Adrenergic Receptors (Adrenergic Receptor)IBA
11/2006 |
| 1 | PrenalterolIBA
11/2006 |
| 1 | Isoproterenol (Isoprenaline)FDA LinkGeneric
11/2006 |
| 1 | ICI 118551IBA
11/2006 |
| 1 | FenoterolIBA
11/2006 |
| 1 | LipopolysaccharidesIBA
06/2004 |
| 1 | EndotoxinsIBA
06/2004 |
| 1 | Presynaptic ReceptorsIBA
06/2004 |
| 1 | Cannabinoid Receptor AgonistsIBA
03/2003 |
| 1 | Capsaicin (Zostrix)FDA Link
03/2003 |
| 1 | phenyl biguanideIBA
03/2003 |
| 1 | (3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
03/2003 |